Apolipoprotein A1: A new serum marker correlated to JAK2 V617F proportion at diagnosis in patients with polycythemia vera-Reference-Cited by-同舟云学术

Apolipoprotein A1: A new serum marker correlated to JAK2 V617F proportion at diagnosis in patients with polycythemia vera

Published:2007-12 Issue:12 Volume:1 Page:1605-1612
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Mossuz Pascal,Bouamrani Ali,Brugière Sabine,Arlotto Marie,Hermouet Sylvie,Lippert Eric,Laporte François,Girodon François,Dobo Irène,Vincent Praloran,Garin Jérome,Cahn Jean Yves,Berger François

Funder

Direction de la Recherche Clinique, CHU Grenoble

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.200601051/fullpdf

Reference26 articles.

1. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera;James;Nature,2005

2. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis;Levine;Cancer Cell,2005

3. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

4. A gain of function mutation of JAK2 in myeloproliferative disorders;Kralovics;New Engl. J. Med.,2005

5. Identification of an acquired JAK2 mutation in Polycythemia Vera;Zhao;J. Biol. Chem.,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute myocardial infarction in myeloproliferative neoplasms;World Journal of Cardiology;2023-11-26

2. Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2020-12-31

3. Association between proteomic profile and molecular response in chronic myeloid leukemia patients;Leukemia & Lymphoma;2017-07-11

4. Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with JAK2 Mutation Status;Molecular Cancer Research;2017-03-17

5. Ph− myeloproliferative neoplasm red blood cells display deregulation of IQGAP1-Rho GTPase signaling depending on CALR/JAK2 status;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2016-11